ZunAn is focusing on the technological development of manufacturing procedure and new molecules, by its R&D department and contract institutes, to support its manufacturing and contract manufacturers and provide the competitive bulk drugs and the advanced new molecules. ZunAn is also committed to develop the innovative or combined formulation to promote the domestic marketing of the finished drugs and assist the international partners to develop the new products.
Manufacturer of Raw Materials
ZunAn is manufacturing the high quality and competitive bulk drugs and intermediates of anti-neoplastic agents, cephalosporin serials, Rifamycin serials and other advanced agents, meted USP, EP, BP or CP standards, with extremely tight limits for impurities and solvents and state-of-the-art process in the GMP and ISO certificated facilities. As a global supplier, its materials have been used in the approved ANDA drugs in over 20 countries and regions for the past decade.
Custom Synthesis
Custom synthesis is an important part of our business. We will also provide any compound that does not appear in our catalogue. Moreover we accept customer requests to increase a current production and other manufacturing orders applying to a similar reaction or by a new synthetic route.
Sourcing for Bulk Drugs
Hundreds of partners, with GMP and ISO certificated and international standard facilities and under ZunAn technology supports, assure the supply capabilities the listed superior products about API, intermediates, agrochemicals, neutraceuticals, plant extracts and cosmetic additives.
Technology Services
1.New technology of finished preparations.
2.Various pellets of control-released or delay-released.
3.Synthesis of special compounds.
4.The import & export of special technology.
Consulting Services
1.Registration for license of products and application in China.
2.Consulting for international or domestic companies about the marketing, R&D and cooperation in China
Domestic Whole-sale Marketing
ZunAn has the personnel to promote the marketing of international branded or generic drug in China as the agent, and develops, manufactures and distributes the finished drugs in domestic market. |